Temporomandibular Disorders, Neuropathic and Idiopathic Orofacial Pain, and Headaches: a Literature Review
Andrew Young,Ladan Sahabi,Noboru Noma,Mythili Kalladka,Zhimin Yan
DOI: https://doi.org/10.21037/fomm-21-86
2023-01-01
Frontiers of Oral and Maxillofacial Medicine
Abstract:Background and Objective: Temporomandibular disorders (TMDs), headaches, and neuropathic, nociplastic, and idiopathic orofacial pain (OFP) overlap several specialties for diagnosis and management. A significant proportion of patients achieve inadequate pain relief. This article is intended to provide for practitioners an overview of the current diagnostic criteria and treatments. Methods: PubMed and the Cochrane Database of Systematic Reviews were searched from 2000 to 2021 for human and English studies that involved comparison groups, and systematic reviews of such studies. Key Content and Findings: Internationally-accepted diagnostic criteria now for exist all types of TMDs, headaches, and neuropathic, nociplastic, and idiopathic OFP. TMDs are managed by addressing the causative factors where known; and by using intraoral appliances (IA), medications and physical therapy (PT), amongst other modalities. Medications can be systemic, topical, or injected. Neuropathic, nociplastic, and idiopathic OFP treatments are mainly systemic medications, though supplements and topical agents are being used more frequently. Headaches are managed primarily with systemic medications. Botox, psychological treatment, and lifestyle changes are also used. Conclusions: The diagnosis of these pain conditions has become increasingly standardized, with validated and internationally-accepted diagnostic criteria. The greatest need is for more analysis of existing treatments and development of new therapeutics for neuropathic, nociplastic, and idiopathic OFP and headache.